Singapore markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
19.50-1.26 (-6.07%)
At close: 04:00PM EST
19.50 0.00 (0.00%)
After hours: 04:00PM EST

PROCEPT BioRobotics Corporation

900 Island Drive
Redwood City, CA 94065
United States
650 232 7200
https://www.procept-biorobotics.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Reza Zadno Ph.D.Pres, CEO & Director652.8kN/A1955
Mr. Kevin WatersSr. VP & CFO565.38kN/A1977
Mr. Hisham ShiblaqSr. VP of Global Commercialization450.23kN/A1975
Mr. Mohan F. SanchetiVP of OperationsN/AN/A1964
Ms. Alaleh NouriSr. VP, Gen. Counsel & Corp. Sec.N/AN/A1979
Ms. Minni VittalVP of PeopleN/AN/AN/A
Mr. Surag MantriSr. VP of R&DN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Corporate governance

PROCEPT BioRobotics Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.